US2009030001A1PendingUtilityA1

Therapeutic agent for corneal disease

Assignee: TEIKA PHARMACEUTICAL CO LTDPriority: Apr 27, 2005Filed: Apr 27, 2006Published: Jan 29, 2009

Est. expiryApr 27, 2025(expired)· nominal 20-yr term from priority

Inventors:Takahito Kimura Shigeto Fujishita Hiroyoshi Kawada

A61P 27/02A61K 9/0048C07D 251/18A61K 31/53

PatentIndex Score

Cited by

References

Claims

Abstract

A therapeutic agent for a corneal disease comprising irsogladine or a salt thereof as an active ingredient. The purpose is to find a substance capable of effectively treating/ameliorating a corneal disease which has been increased in the number of cases thereof in recent years and to provide a therapeutic agent for a corneal disease comprising the substance as an active ingredient.

Claims

exact text as granted — not AI-modified

1 . A therapeutic agent for a corneal disease comprising irsogladine or a salt thereof as an active ingredient. 
   
   
       2 . The therapeutic agent for a corneal disease according to  claim 1 , in the form of an ophthalmic solution. 
   
   
       3 . The therapeutic agent for a corneal disease according to either  claim 1  or  2 , being applicable to a disorder in the anterior epithelium of cornea.

Join the waitlist — get patent alerts

Track US2009030001A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.